CHEK1 and brain neoplasm: A search of the NIH ClinicalTrials.gov database [126] for clinical trials on cell cycle checkpoint inhibitors in brain tumors identified two trials on inhibitors of ATM and CHK1, respectively, and five on the WEE1 inhibitor AZD1775 (Table 2).